Matinas Biopharma Holdings IMTNB
13F holders, Q3 2024 (September 30)17holders
$3.49avg. 13F price*
At the end of Q3 2024, 17 institutions reported holding Matinas Biopharma Holdings I (MTNB) in their 13F filings. The largest holders were Vanguard Group Inc. ($660K), Highbridge Capital Management LLC ($457K) and Sargent Investment Group, LLC ($284K).
- Company
- Matinas Biopharma Holdings I
- CUSIP
- 576810303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $1.7M |
| Exits | 0 | $0 |
Ownership 17 holders
| Vanguard Group Inc. | 0.00% | New | 186,357 | $660K |
| Highbridge Capital Management LLC | 0.08% | New | 128,956 | $457K |
| Sargent Investment Group, LLC | 0.05% | New | 80,240 | $284K |
| BlackRock, Inc. | 0.00% | — | 49,650 | $176K |
| Geode Capital Management, LLC | 0.00% | New | 46,729 | $165K |
| Squarepoint Ops LLC | 0.00% | New | 20,601 | $73K |
| State Street Corp. | 0.00% | New | 15,322 | $54K |
| UBS Group AG | 0.00% | New | 3,427 | $12K |
| Sanctuary Advisors, LLC | 0.00% | New | 10,004 | $6K |
| Wells Fargo & Company | 0.00% | New | 1,102 | $4K |
| Bank of America Corp. | 0.00% | New | 1,016 | $4K |
| JPMorgan Chase & Co. | 0.00% | New | 912 | $3K |
| Morgan Stanley | 0.00% | New | 520 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $707 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 61 | $216 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 60 | $212 |
| Rothschild Investment LLC | 0.00% | New | 14 | $50 |
"% of holder's portfolio" is MTNB's weight in each manager's 13F, not the share of Matinas Biopharma Holdings I the manager owns.